Tissue Engineering & Implants

Biomedical Porosimetry

Optimize tissue scaffolds, bone grafts, and medical implants through precise porosity, pore interconnectivity, and surface area characterization for enhanced biointegration.

Explore Solutions Get Testing Quote
$425B
Medical Device Market
70-90%
Scaffold Porosity Target
100μm
Optimal Pore Size for Bone
6-12mo
Biodegradation Timeline

Tissue Engineering Scaffolds

Pore architecture critical for cell infiltration, nutrient transport, and tissue regeneration

Bone Tissue Scaffolds

Optimal Pore Architecture

  • Porosity: 70-90% for bone ingrowth
  • Pore size: 100-500 μm optimal
  • Interconnectivity: >90% essential
  • Pore throat: >50 μm for vascularization
2026 Insight: 3D-printed scaffolds with gradient porosity achieve 95% bone integration in 6 months.

Key Measurements

  • Mercury intrusion for macro/mesopore distribution
  • Micro-CT integration for 3D pore network
  • BET surface area for protein adsorption
  • Interconnectivity mapping via image analysis

Soft Tissue Scaffolds

Cell-Specific Requirements

  • Porosity: 60-85% for cell migration
  • Pore size: 20-150 μm for soft tissue
  • Mechanical properties: Balanced with porosity
  • Degradation rate: Matches tissue growth
Tissue Engineering: Electrospun scaffolds mimic native ECM with 50-500 nm fiber spacing.

Critical Parameters

  • Fiber diameter and spacing (electrospun)
  • Hydrogel mesh size determination
  • Degradation-induced porosity changes
  • Swelling behavior in aqueous media

Medical Implant Applications

Orthopedic Implants

Material Ti, HA, PEEK
Porosity 30-70%
Pore size 200-600 μm
Surface area 0.5-5 m²/g
Goal Osseointegration

Porous coating enables bone ingrowth and stability

Dental Implants

Material Ti with HA coating
Surface roughness 1-10 μm Ra
Micro-porosity 20-50%
SA enhancement 4-6× vs smooth
Integration 3-6 months

Surface topography critical for cell adhesion

Cardiovascular Devices

Type Stents, heart valves
Coating porosity 40-70%
Drug release Controlled by pores
Pore size 0.1-10 μm
Function Endothelialization

Porous coatings reduce thrombogenicity

Biodegradation & Cell Infiltration

Degradation Kinetics

Monitor porosity evolution as scaffolds degrade to match tissue regeneration timeline.

  • PLGA/PLA: 6-24 month degradation
  • Porosity increase: 30% → 90% over time
  • Pore size expansion enables vascularization
  • Mechanical strength vs porosity trade-off
Target: Complete resorption at tissue maturity

Cell Migration & Proliferation

Optimize pore architecture for cell infiltration depth and uniform tissue formation.

  • Minimum pore size: 3× cell diameter
  • Interconnect size: >10 μm for migration
  • Porosity gradient strategies
  • Nutrient diffusion: limited to 200 μm
Goal: 100% infiltration in 4-8 weeks

Protein Adsorption

Surface area and nanopore structure govern protein adsorption affecting cell response.

  • BET surface area: 1-100 m²/g range
  • Nanopores (2-50 nm): Protein entrapment
  • Surface chemistry + topography synergy
  • Fibronectin/vitronectin preferential adsorption
Enhancement: 5× cell adhesion with optimized SA

Vascularization

Large interconnected pores essential for blood vessel ingrowth and long-term viability.

  • Minimum pore: 100 μm for capillaries
  • Optimal: 300-400 μm for rapid vascularization
  • Permeability >10⁻⁹ m² for fluid flow
  • Angiogenic factor release from pores
Critical: Vascularization by week 2-3

Testing Standards & Methods

Property Test Method Standard Application
Porosity Mercury intrusion or liquid displacement ASTM F2450 All scaffolds
Pore size distribution MIP, micro-CT, SEM ASTM F2450 Bone/soft tissue
Interconnectivity Micro-CT 3D analysis ISO 10993 Critical for ingrowth
Surface area BET (N₂ or Kr) ISO 9277 Protein adsorption
Mechanical properties Compression testing ASTM F2150 Porosity correlation
Degradation Time-series porosity ASTM F1635 Bioresorbable materials

Clinical Case Studies

Spinal Fusion Cage Optimization

Challenge: Design PEEK cage with optimal porosity for bone ingrowth

Solution: 3D-printed gradient porosity structure (40% to 70%)

  • Pore size: 300-500 μm in core region
  • Bone ingrowth: 85% at 6 months
  • Fusion rate: 95% vs 78% for solid cages
Achievement: FDA 510(k) clearance Q4 2025

Cartilage Regeneration Scaffold

Challenge: Develop scaffold for knee cartilage repair with zonal architecture

Solution: Bilayer PCL scaffold with depth-dependent pore structure

  • Superficial layer: 50-100 μm pores
  • Deep layer: 150-300 μm pores
  • Chondrocyte viability: >90% at 12 weeks
Result: Phase II trial showing 75% defect healing

Drug-Eluting Bone Graft

Challenge: Controlled antibiotic release from calcium phosphate bone substitute

Solution: Hierarchical pore structure for dual-release kinetics

  • Macropores (200-400 μm): Bone ingrowth
  • Mesopores (5-50 nm): Drug reservoir
  • Release duration: 6-8 weeks sustained
Impact: Zero infections in 500 patient trial

Advance Your Biomedical Device Development

Expert porosimetry testing for tissue engineering and medical device optimization

Request Analysis Porosity Calculator